DOI QR코드

DOI QR Code

Predicting Lympho-Vascular Space Invasion in Endometrial Cancers with Mucinous Carcinomatous Components

  • Ilker, Selcuk (Gynecologic Oncology Unit, Zekai Tahir Burak Women's Health, Education and Research Hospital) ;
  • Nilufer, Cetinkaya (Gynecologic Oncology Unit, Zekai Tahir Burak Women's Health, Education and Research Hospital) ;
  • Firat, Cuylan Zeliha (Gynecologic Oncology Unit, Zekai Tahir Burak Women's Health, Education and Research Hospital) ;
  • Bulent, Ozdal (Gynecologic Oncology Unit, Zekai Tahir Burak Women's Health, Education and Research Hospital) ;
  • Hatice, Bayramoglu (Pathology Unit, Zekai Tahir Burak Women's Health, Education and Research Hospital) ;
  • Tayfun, Gungor (Department of Obstetrics and Gynecology, Hitit University, Faculty of Medicine)
  • Published : 2015.06.03

Abstract

Objective: To determine the predictors of lympho-vascular space invasion (LVSI) in endometrial cancers which contain mucinous carcinomatous histology. Materials and Methods: Clinical and histopathological data of endometrial carcinomas with a mucinous carcinomatous component diagnosed between January 2007 and January 2014 at the Gynecologic Oncology Department of Zekai Tahir Burak Women's Health Education and Research Hospital were reviewed retrospectively. Results: Twelve patients (25.5%) were positive for LVSI and 35 (74.5%) patients were negative. Patients with LVSI were mostly staged higher than 1A. Mean age, BMI and parity were not significantly different between patient groups. Larger tumor diameter (${\geq}2cm$) (p=0.04) and elevated Ca125 and Ca-19.9 (p=0.01) levels were significant for predicting LVSI. We also found>1/2 myometrial invasion (p<0.001), cervical stromal involvement (p=0.002) and higher grade (2-3) (p=0.001) significant for predicting LVSI. In multivariate analysis we found only grade significant for predicting LVSI. Conclusions: Especially grade of tumor is a crucial factor for determining LVSI in endometrial cancers with mucinous carcinomatous components.

Keywords

References

  1. Ayeni TA, Bakkum-Gamez JN, Mariani A, et al (2013). Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas. Gynecol Oncol, 129, 478-85. https://doi.org/10.1016/j.ygyno.2013.03.011
  2. Binesh F, Akhavan A, Behniafard N, et al (2014). Endometrial adenocarcinoma: clinicopathologic and survival characteristics in Yazd, Iran. Asian Pac J Cancer Prev, 15, 2797-801. https://doi.org/10.7314/APJCP.2014.15.6.2797
  3. Cetinkaya K, Atalay F, Bacinoglu A (2014). Risk factors of lymph node metastases with endometrial carcinoma. Asian Pac J Cancer Prev, 15, 6353-6. https://doi.org/10.7314/APJCP.2014.15.15.6353
  4. Chung HH, Kim JW, Park NH, et al (2006). Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand, 85, 1501-5. https://doi.org/10.1080/00016340601022777
  5. Creasman WT, Morrow CP, Bundy BN, et al (1987). Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer, 60, 2035-41. https://doi.org/10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8
  6. Ebina Y, Sakuragi N, Hareyama H, et al (2002). Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma. Acta Obstet Gynecol Scand, 81, 458-65. https://doi.org/10.1034/j.1600-0412.2002.810514.x
  7. Felix AS, Weissfeld JL, Stone RA, et al (2010). Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control, 21, 1851-6. https://doi.org/10.1007/s10552-010-9612-8
  8. Gungor T, Kanat-Pektas M, Ustunyurt E, et al (2009). Synchronous primary tumors of the female genital tract: a single center experience. Arch Gynecol Obstet, 279, 667-72. https://doi.org/10.1007/s00404-008-0800-7
  9. Guntupalli SR, Zighelboim I, Kizer NT, et al (2012). Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. Gynecol Oncol, 124, 31-5. https://doi.org/10.1016/j.ygyno.2011.09.017
  10. Jalloul RJ, Elshaikh MA, Ali-Fehmi R, et al (2012). Mucinous adenocarcinoma of the endometrium: case series and review of the literature. Int J Gynecol Cancer, 22, 812-8. https://doi.org/10.1097/IGC.0b013e31824aa877
  11. Kelly PJ, Archbold P, Price JH, et al (2010). Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype. J Clin Pathol, 63, 169-73. https://doi.org/10.1136/jcp.2009.072355
  12. Larson DM, Connor GP, Broste SK, et al (1996). Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol, 88, 394-8. https://doi.org/10.1016/0029-7844(96)00161-5
  13. Mariani A, El-Nashar SA, Dowdy SC (2010). Lymphadenectomy in endometrial cancer: which is the right question? Int J Gynecol Cancer, 20, S52-4. https://doi.org/10.1111/IGC.0b013e3181f60d0f
  14. Mariani A, Webb MJ, Keeney GL, et al (2001). Role of wide/ radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol Oncol, 83, 72-80. https://doi.org/10.1006/gyno.2001.6346
  15. Melhem MF, Tobon H (1987). Mucinous adenocarcinoma of the endometrium: a clinico-pathological review of 18 cases. Int J Gynecol Pathol, 6, 347-55. https://doi.org/10.1097/00004347-198712000-00007
  16. Morrow CP, Bundy BN, Kurman RJ, et al (1991). Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol, 40, 55-65. https://doi.org/10.1016/0090-8258(91)90086-K
  17. Musa F, Huang M, Adams B, et al (2012). Mucinous histology is a risk factor for nodal metastases in endometrial cancer. Gynecol Oncol, 125, 541-5. https://doi.org/10.1016/j.ygyno.2012.03.004
  18. Natee J, Kietpeerakool C, Srisomboon J, et al (2006). Clinicopathologic analysis of women with synchronous primary carcinomas of the endometrium and ovary: 10- year experience from Chiang Mai university hospital. Asian Pac J Cancer Prev, 7, 234-8.
  19. Patsavas K, Woessner J, Gielda B, et al (2011). Optimal surgical debulking in uterine papillary serous carcinoma affects survival. Gynecol Oncol, 121, 581-5. https://doi.org/10.1016/j.ygyno.2010.11.048
  20. Rauh-Hain JA, Vargas RJ, Clemmer J, et al (2014). Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis. Am J Clin Oncol. [Epub ahead of print].
  21. Sanjuan A, Cobo T, Pahisa J, et al (2006). Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section. Int J Gynecol Cancer, 16, 385-90. https://doi.org/10.1111/j.1525-1438.2006.00414.x
  22. Schink JC, Lurain JR, Wallemark CB, et al (1987). Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis. Obstet Gynecol, 70, 216-9.
  23. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
  24. Taskiran C, Yuce K, Geyik PO, et al (2006). Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer. Int J Gynecol Cancer, 16, 1342-7. https://doi.org/10.1111/j.1525-1438.2006.00534.x
  25. Vaizoglu F, Yuce K, Salman MC, et al (2013). Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer. Arch Gynecol Obstet, 288, 1391-7. https://doi.org/10.1007/s00404-013-2913-x
  26. Wilairat W, Benjapibal M (2012). Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev, 13, 3187-90. https://doi.org/10.7314/APJCP.2012.13.7.3187

Cited by

  1. Accuracy of Sentinel Node in Detecting Lymph Node Metastasis in Primary Endometrial Carcinoma vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6691